Showing results (1-10 of 1,342) with videos related to

Sort By:
Pageof 135
European Archives of Psychiatry and Clinical Neuroscience|December 15, 2010
Obesity and coronary risk in patients treated with second-generation antipsychoticsChristoph U Correll, John M Kane, Peter Manu
The Journal of Clinical Psychiatry|June 16, 2011
Sudden deaths in psychiatric patientsPeter Manu, John M Kane, Christoph U Correll
The Journal of Clinical Psychiatry|July 12, 2013
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?Jimmi Nielsen, Christoph U Correll, Peter Manu, et al.
Bipolar Disorders|November 27, 2008
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychoticsChristoph U Correll, Anne M Frederickson, John M Kane, et al.
The Journal of Clinical Psychiatry|May 4, 2006
Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugsChristoph U Correll, Anne M Frederickson, John M Kane, et al.
Schizophrenia Research|October 31, 2006
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?Christoph U Correll, Anne M Frederickson, John M Kane, et al.
Journal of Child and Adolescent Psychopharmacology|August 10, 2011
Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control studyChristoph U Correll, Jennifer Harris, Vicki Figen, et al.
Schizophrenia Research|April 8, 2014
Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatientsPetru Ifteni, Christoph U Correll, Victoria Burtea, et al.
Pageof 135